Table 1.
Hospitalizations at 15 days, 30 days, and 140 days following SP treatment.
| Groups | N | Day 15 | Day 30 | Day 140 | |||
|---|---|---|---|---|---|---|---|
| SP and | n | RR (95% CI) | n | RR (95% CI) | n | RR (95% CI) | |
| Placebo | 552 | 17 | — | 23 | — | 63 | — |
| Folic acid | 1096 | 25 | 0.73 (0.38–1.45) | 39 | 0.85 (0.49–1.49) | 119 | 0.95 (0.69–1.30) |
| Fe/FA | 550 | 14 | 0.82 (0.38–1.77) | 19 | 0.82 (0.42–1.58) | 62 | 0.99 (0.68–1.42) |
| Fe/FA/Zn | 546 | 11 | 0.65 (0.27–1.46) | 20 | 0.87 (0.46–1.67) | 57 | 0.90 (0.62–1.32) |
SP: sulfadoxine and pyrimethamine; Fe: iron; FA: folic acid; Zn: zinc.
Folic acid = Fe/FA and Fe/FA/Zn groups.